Dividend compounder review

DXRX

Diaceutics PLC · LSE · GB

Healthcare · Health Information Services

Chart Factor Intelligence Back to Screener
Score36.50/100
Confidence78.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 7.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 19.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 7.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income£97,000
Free Cash Flow£-5.3M
FCF Covers DividendUnknown
Debt / Equity2.85
P/E-
Revenue Growth 5Y25.4%
Net Margin0.3%
ROE0.2%
Price vs Trend-6.9%
3Y Return65.7%
5Y Return9.6%
CurrencyGBP
Warnings

Review flags

No usable dividend history found.
Free cash flow is negative.
Debt to equity is elevated at 2.85.
Dividend diary

Activity record

DXRX dividend review warning Warning · Warning

Debt to equity is elevated at 2.85.